Atlas Trials

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Clinical trial NCT00131612 · TERMINATED

Trial details

NCT number
NCT00131612
Sponsor
AHS Cancer Control Alberta
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2002-01-01
Primary completion
2005-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.